New Industrial Systems: Optimising Me Manufacturing Systems

Lead Research Organisation: University of Kent
Department Name: Sch of Physical Sciences

Abstract

The Optimising Me Manufacturing System [OMMS] project is developing a healthcare microfactory that provides on-the-body manufacturing of therapeutics. The concept arose during the EPSRCs New Industrial Systems workshop held in May 2017, bringing together researchers from a diverse range of disciplines to work together to create transformative impact on our manufacturing industries. The initial proof-of-concept focuses on the development of a manufacturing system for T-cell immunotherapies, located on the body and delivered on demand in response to the patient's needs. The long-term vision the creation of modular microfactories, built using a range of underlying common technologies, enabling future on-body manufacturing of a range of different therapeutics.

OMMS goes beyond the current state of the art and re-defines healthcare manufacturing. It offers a step change in current manufacturing trajectories, enabling responsive delivery of bespoke therapeutics as part of a distributed manufacturing system. T-cell delivery was chosen chosen specifically because of its demonstrable therapeutic capability. In September 2017, they will become the first gene therapy to have been approved by the US FDA. From the clinical data presented thus far it appears these genetically modified T-cells present a CURE for some of the most aggressive forms of cancer (Acute Lymphoblastic Leukaemia, Chronic Lymphoblastic Leukaemia). The current manufacture of T-cells is undertaken in a laboratory and can take up to 21 days, depending on the quality of the patient's starting cellular material. The long, complex and expensive process poses the risk of contamination and further complications due to patient variations. The development of a continuous manufacturing capability will address some of these shortcomings and would allow the continuous manufacture and delivery of the therapy to the patient. Moving therapeutic manufacturing away from the current one-size-fits-all approach could enable advances which deliver patient-specific therapies of sufficient precision and quality for personalised medicine.

By creating a proof-of-concept platform within a very short timeline, OMMS will demonstrate distributed therapeutic manufacture on/at-patient, with clear scope for extension towards other pharmaceutical manufacturing targets e.g. diabetes monitoring and control. The project takes steps towards de-risking the development of key technologies in on-body integration, manufacturing process and biometrology (measurement of the product throughout the microfactory to ensure that strict quality and regulatory requirements are met). The development of technologies that are transferable to a number of future healthcare manufacturing systems will pave the way for the broader uptake of the microfactory platform concept.

The project has three main over-arching objectives:
1. Proof-of-concept for a new microfactory platform for therapeutic manufacturing, moving pharmaceutical manufacturing from a non-responsive, centralized process towards a bespoke, distributed manufacturing process.
2. Direct engagement with industrialists, academics and policy makers towards this new vision of therapeutic and healthcare manufacturing in the U.K.
3. Delivery of a prototype of the microfactory platform, based on T-cell immunotherapy, incorporating 4 main elements into the factory on-body:
a. Specific cell isolation directly from the patient's blood.
b. Processing of these raw materials towards a deliverable therapeutic.
c. Complete integration of biometrology, to ensure quality control, from isolation through the microfactory process.
d. Fully integrated feedback between the location, biometrology and manufacturing process phases of the microfactory, responding dynamically to demand and quality parameters.

Planned Impact

It is expected that the OMMS project will result in multiple levels of impact for a range of different beneficiaries from academic in the short term, through to industrial, clinical, regulatory, patient groups and the general public in the long term.

Once the vision of a personalised microfactory is realised, the primary beneficiary will be patients who will benefit from increasing levels of targeted therapeutic precision and improved clinical outcomes. In particular, the exemplar selected for the OMMS project is one that is both timely and clinically-relevant given the successful clinical trial data and the potential to develop an effective therapy against aggressive forms of cancer (acute lymphoblastic leukaemia and chronic lymphoblastic leukaemia). Moreover, this project aims to redefine the manufacture of therapeutics by moving away from the existing 'one-size-fits-all' approach to a more personalised and targeted, distributed manufacturing, approach which is not only relevant for the clinical exemplar selected, but has the potential to be applied as a platform to a wide variety of clinical indications.

The project is also expected to deliver significant impact and align with the UK's advanced therapeutic R&D and manufacturing agenda. This will complement activity of existing UK infrastructure projects such as the Cell and Gene Therapy and Precision Medicines Catapults in addition to the UK-wide research activities in this sector including the UK Regenerative Medicine Platform, the EPSRC Targeted Manufacturing Healthcare Hub and the EPSRC-MRC Centres for Doctoral Training.

As identified in the academic beneficiaries summary, there is significant potential for the research outcomes from this project in addition to the extensive multidisciplinary approach adopted by the project investigators to create impact within the academic community. This will enhance existing research activity in this sector but, specifically, will redefine and create a new manufacturing, business model and supply chain paradigm for the production and delivery of advanced therapeutics. Similar to the redistributed manufacturing approach, this project will look to establish a manufacturing approach not just close to clinic, but on/at patient, utilising the body's innate ability and regenerative potential.

Key beneficiaries also include industry, not just the healthcare manufacturing sector, but also other sectors which can benefit from personalisation, enhanced biometrology, self-powered sensors and novel business, supply chain and manufacturing models. Specifically, if the project vision is realised, the microfactory platform will have significant impact on the manufacture and supply of advanced therapies and can act as a platform system for the isolation and delivery of other therapeutics. Such a system is likely to be of interest to large pharmaceutical and biopharmaceutical companies (i.e. GSK, Pfizer, Novartis), vendor companies (i.e. Sartorius, Pall and GE Healthcare), SMEs, both UK and international (i.e. Autolus, Excellthera and Orchard Therapeutics) and CMOs (i.e. PCT, FujiFilm Diosynth and Lonza).

Other beneficiaries include the NHS and clinicians and has the potential to alleviate pressures for frontline staff as well as resource requirements by reducing the burden of acute and chronic conditions. Moreover, through the use of automated monitoring and dose formulation/administration, the microfactory platform has the potential to significant reduce human error and improve consistency. It is also expected that the research will result in the creation of new research-led teaching and training material which can be provided to industry delegates (e.g. through UCL MBI industry courses) or to undergraduate and postgraduate students across the field of bioengineering, materials science, management and electronic and electrical engineering.

Publications

10 25 50

publication icon
Díaz-Fernández A (2022) An impedimetric immunosensor for the selective detection of CD34+ T-cells in human serum in Sensors and Actuators B: Chemical

 
Title "Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading) 
Description This video is the tenth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. "Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading) Bio: Al Edwards has a background in fundamental immunology combined with expertise in biochemical engineering, he is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology. The two main challenges he currently works on are the development of affordable microfluidics for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines. Alexander's research is funded from a wide range of sources, including NIHR , EPSRC, SBRI Healthcare, the Wellcome Trust, Innovate UK and industry Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/21a78Vql8b0 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7117170
 
Title "Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading) 
Description This video is the tenth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. "Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading) Bio: Al Edwards has a background in fundamental immunology combined with expertise in biochemical engineering, he is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology. The two main challenges he currently works on are the development of affordable microfluidics for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines. Alexander's research is funded from a wide range of sources, including NIHR , EPSRC, SBRI Healthcare, the Wellcome Trust, Innovate UK and industry Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/21a78Vql8b0 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7117169
 
Title Artificial intelligence for identification of blood cells - Prof Huiyu Zhou (University of Leicester) 
Description This video is the eleventh talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. Artificial intelligence for identification of blood cells - Prof Huiyu Zhou (University of Leicester) Bio: Prof. Huiyu Zhou received a Bachelor of Engineering degree in Radio Technology from Huazhong University of Science and Technology of China, and a Master of Science degree in Biomedical Engineering from University of Dundee of United Kingdom, respectively. He was awarded a Doctor of Philosophy degree in Computer Vision from Heriot-Watt University, Edinburgh, United Kingdom. Dr. Zhou currently is a full Professor at School of Computing and Mathematical Sciences, University of Leicester, United Kingdom. He has published over 400 peer-reviewed papers in the field. He was the recipient of "CVIU 2012 Most Cited Paper Award", "MIUA 2020 Best Paper Award", "ICPRAM 2016 Best Paper Award" and was nominated for "ICPRAM 2017 Best Student Paper Award" and "MBEC 2006 Nightingale Prize". His research work has been or is being supported by UK EPSRC, ESRC, AHRC, MRC, EU, Royal Society, Leverhulme Trust, Puffin Trust, Alzheimer's Research UK, Invest NI and industry. Homepage: https://le.ac.uk/people/huiyu-zhou. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/N5AjIUAwYp4 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7117192
 
Title Artificial intelligence for identification of blood cells - Prof Huiyu Zhou (University of Leicester) 
Description This video is the eleventh talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. Artificial intelligence for identification of blood cells - Prof Huiyu Zhou (University of Leicester) Bio: Prof. Huiyu Zhou received a Bachelor of Engineering degree in Radio Technology from Huazhong University of Science and Technology of China, and a Master of Science degree in Biomedical Engineering from University of Dundee of United Kingdom, respectively. He was awarded a Doctor of Philosophy degree in Computer Vision from Heriot-Watt University, Edinburgh, United Kingdom. Dr. Zhou currently is a full Professor at School of Computing and Mathematical Sciences, University of Leicester, United Kingdom. He has published over 400 peer-reviewed papers in the field. He was the recipient of "CVIU 2012 Most Cited Paper Award", "MIUA 2020 Best Paper Award", "ICPRAM 2016 Best Paper Award" and was nominated for "ICPRAM 2017 Best Student Paper Award" and "MBEC 2006 Nightingale Prize". His research work has been or is being supported by UK EPSRC, ESRC, AHRC, MRC, EU, Royal Society, Leverhulme Trust, Puffin Trust, Alzheimer's Research UK, Invest NI and industry. Homepage: https://le.ac.uk/people/huiyu-zhou. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/N5AjIUAwYp4 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7117191
 
Title Collaborative Innovation Project funding launch - Dr Samantha Kanza (University of Reading, University of Southampton) 
Description This video is the eighth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Collaborative Innovation Project funding launch - Dr Samantha Kanza (University of Reading) Bio: Dr Samantha Kanza is a Senior Enterprise Fellow at the University of Southampton. She completed her MEng in Computer Science at the University of Southampton and then worked for BAE Systems Applied Intelligence for a year before returning to do an iPhD in Web Science (in Computer Science and Chemistry), which focused on Semantic Tagging of Scientific Documents and Electronic Lab Notebooks. She was awarded her PhD in April 2018. Samantha works in the interdisciplinary research area of applying computer science techniques to the scientific domain, specifically through the use of semantic web technologies and artificial intelligence. Her research includes looking at electronic lab notebooks and smart laboratories, to improve the digitization and knowledge management of the scientific record using semantic web technologies; and using IoT devices in the laboratory. She has also worked on a number of interdisciplinary Semantic Web projects in different domains, including agriculture, chemistry and the social sciences. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/PDWZkZBzfqw 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7117155
 
Title Collaborative Innovation Project funding launch - Dr Samantha Kanza (University of Reading, University of Southampton) 
Description This video is the eighth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Collaborative Innovation Project funding launch - Dr Samantha Kanza (University of Reading) Bio: Dr Samantha Kanza is a Senior Enterprise Fellow at the University of Southampton. She completed her MEng in Computer Science at the University of Southampton and then worked for BAE Systems Applied Intelligence for a year before returning to do an iPhD in Web Science (in Computer Science and Chemistry), which focused on Semantic Tagging of Scientific Documents and Electronic Lab Notebooks. She was awarded her PhD in April 2018. Samantha works in the interdisciplinary research area of applying computer science techniques to the scientific domain, specifically through the use of semantic web technologies and artificial intelligence. Her research includes looking at electronic lab notebooks and smart laboratories, to improve the digitization and knowledge management of the scientific record using semantic web technologies; and using IoT devices in the laboratory. She has also worked on a number of interdisciplinary Semantic Web projects in different domains, including agriculture, chemistry and the social sciences. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/PDWZkZBzfqw 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7117154
 
Title Communicating with the Network & Landscape Workshops - Dr Samantha Kanza (University of Reading, University of Southampton) 
Description This video is the eleventh talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Communicating with the Network & Landscape Workshops - Dr Samantha Kanza (University of Southampton). Bio: Dr Samantha Kanza is an Enterprise Fellow at the University of Southampton. She completed her MEng in Computer Science at the University of Southampton and then worked for BAE Systems Applied Intelligence for a year before returning to do an iPhD in Web Science (in Computer Science and Chemistry), which focused on Semantic Tagging of Scientific Documents and Electronic Lab Notebooks. She was awarded her PhD in April 2018. Samantha works in the interdisciplinary research area of applying computer science techniques to the scientific domain, specifically through the use of semantic web technologies and artificial intelligence. Her research includes looking at electronic lab notebooks and smart laboratories, to improve the digitization and knowledge management of the scientific record using semantic web technologies; and using IoT devices in the laboratory. She has also worked on a number of interdisciplinary Semantic Web projects in different domains, including agriculture, chemistry and the social sciences. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/fvRb9ULGU2I 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members by telling them how to interact with the Network. 
URL https://zenodo.org/record/7116443
 
Title Detection of drugs & biomarkers in healthcare using optical fibre sensors - Professor Serhiy Korposh 
Description This video is the thirteenth talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023. Detection of drugs and biomarkers in healthcare using optical fibre sensors - Professor Serhiy Korposh (University of Nottingham).  Bio: Serhiy Korposh is an Associate Professor in Electronics, Nanoscale Bioelectronics and Biophotonics at University of Nottingham. His current research focuses on the development of fibre optic sensors and instrumentation for biomedical application from discovery at the interface with physics and chemistry through to application addressing major healthcare challenges. He has published over 100 (h-index 21) peer-reviewed journal and conference papers, book contributions, holds 11 patents (4 licensed to UK and Japanese companies) and given invited presentations at international meetings in the field of optical fibre chemical sensors. He has managed as a PI and Co-I a total funding portfolio of £3.5 million in the area of biomedical point of care sensors. He was a Director of the EPSRC funded Network Cyclops(EP/N026985/1, Closed Loop Control Systems for Optimising Treatment, http://www.healthcaretechnologies.ac.... with the aim to facilitate the formation of a community of academics, clinicians and industrialists, across multiple disciplines (photonic sensing, advanced materials, treatment, and mathematical modelling), including international collaborators to address grand challenges in automation of treatment in healthcare.  Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=vvV2qYsN7iE&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=9 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10277394
 
Title Development of an implantable device for continuous monitoring of blood biomarkers - Dr Chenyang He (University of Nottingham) 
Description This video is the sixth talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  Development of an implantable device for continuous monitoring of blood biomarkers - Dr Chenyang He (University of Nottingham).  Bio: Chenyang He is an early career academic at the University of Nottingham and has been engaged in developing various fibre optic bio-/chemical/physiological sensors for healthcare applications. Examples include point-of-care sensors measuring blood and breath biomarkers of disease through medical devices such as optical fibre-based antibody (IgG) monitoring and anti-cancer drug (Dabrafenib) monitoring and a smart wound dressing for monitoring healing and infection of diabetic foot ulcers (biomarkers: temperature, humidity, NH3 and CO2). These utilise a range of different sensing mechanisms including optical gratings, absorption dyes, Fabry-Perot interferometers and plasmonic nanostructures.  Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=xpB2sznJzqw&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=5 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10277165
 
Title FERRIQ: AI-Driven mapping of disease trajectories - Dr Fayyaz Minhas & Prof Dimitris Grammatopoulos 
Description This video is the fifth talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  FERRIQ: AI-Driven mapping of disease trajectories of patients with genetic iron overload to inform development of clinical decision support systems - Dr Fayyaz Minhas & Professor Dimitris Grammatopoulos (University of Warwick).  Bios: Fayyaz Minhas is an associate professor at Warwick Department of Computer Science. He is also the Deputy Director of the Tissue Image Analytics (TIA) centre and is affiliated with the Pathology image data Lake for Analytics, Knowledge and Education (PathLAKE) consortium. He is a recipient of the Fulbright scholarship and works on solving problems in biology and medicine using machine learning methods as well as the development of bespoke machine learning algorithms in the domains of biomedical informatics, computational pathology, bioinformatics and data science. Specifically, he is interested in designing machine learning models for integrating digital pathology and bioinformatics data for improved diagnosis and therapeutics.  Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust, where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick.  Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=GsAyoVTLYdc&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=4 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10277055
 
Title Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). 
Description This video is the first talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/I1xsig9C8w0 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116818
 
Title Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). 
Description This video is the first talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/I1xsig9C8w0 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Landscape Report Funding Call Town Meeting and helped encourage Network Members to apply for our first funding call. 
URL https://zenodo.org/record/7116819
 
Title Future Blood Testing Network+ Overview and Recap - Dr Weizi (Vicky) Li 
Description This video is the first talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  Future Blood Testing Network+ Overview and Recap - Dr Weizi (Vicky) Li (Henley Business School, University of Reading).  Bio: Weizi (Vicky) Li is a Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is a Fellow of Charted Institute of IT (British Computer Society). She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is currently the Principal Investigator and Director of EPSRC Future Blood Testing for Inclusive Monitoring and Personalised Analytics NetworkPlus; and EPSRC AI for Health project: Advancing machine learning to achieve real-world early detection and personalised disease outcome prediction of inflammatory arthritis. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud-based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 and 4*/3* impact case study in REF 2021 for her research impact on healthcare quality improvement. She is the academic lead of a machine learning-based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received the Research Engagement and Impact award in 2020, shortlisted for 2022 impact award and Health Service Journal (HSJ) patient safety award.  Further details on this event can be found at: https://www.futurebloodtesting.org/fbtn2023  This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/Fqqekmhg79Q?si=l74rXxTFMx42mEsV 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10262672
 
Title Future Blood Testing: Challenges & Opportunities 
Description This video shows the highlights of our Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 Music Licensing details: ASLC-1E1DFFF8-153AD9FEF0 The music is from Adobe Music, is called GUITAR-EPIC-TRAILER-VOCAL_AdobeStock_511629251 YouTube Link: https://youtu.be/OfRa31Wvix8 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7400451
 
Title Future Blood Testing: Challenges & Opportunities 
Description This video shows the highlights of our Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 Music Licensing details: ASLC-1E1DFFF8-153AD9FEF0 The music is from Adobe Music, is called GUITAR-EPIC-TRAILER-VOCAL_AdobeStock_511629251 YouTube Link: https://youtu.be/OfRa31Wvix8 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7400452
 
Title Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li ... 
Description This video is the sixth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li (University of Reading) Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Bing Wang is currently a PhD candidate in informatics and system science at the Informatics Research Center, Henley Business School, University of Reading. Bing's research interests are Natural Language Processing, Machine Learning and Graph Machine Learning. Bing been working as a data scientist at Royal Berkshire NHS Foundation Trust since December 2019 during his PhD. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/W6EH5l80NmU 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7268119
 
Title Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li ... 
Description This video is the sixth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li (University of Reading) Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Bing Wang is currently a PhD candidate in informatics and system science at the Informatics Research Center, Henley Business School, University of Reading. Bing's research interests are Natural Language Processing, Machine Learning and Graph Machine Learning. Bing been working as a data scientist at Royal Berkshire NHS Foundation Trust since December 2019 during his PhD. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/W6EH5l80NmU 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7268118
 
Title Introduction to our Funding Call - Dr Samantha Kanza (University of Reading, University of Southampton). 
Description This video is the second talk from our Landscape Report Funding Call Town Meeting that took place on the 03/02/2022. Introduction to our Funding Call - Dr Samantha Kanza (University of Reading, University of Southampton). Bio: Dr Samantha Kanza is an Enterprise Fellow at the University of Southampton. She completed her MEng in Computer Science at the University of Southampton and then worked for BAE Systems Applied Intelligence for a year before returning to do an iPhD in Web Science (in Computer Science and Chemistry), which focused on Semantic Tagging of Scientific Documents and Electronic Lab Notebooks. She was awarded her PhD in April 2018. Samantha works in the interdisciplinary research area of applying computer science techniques to the scientific domain, specifically through the use of semantic web technologies and artificial intelligence. Her research includes looking at electronic lab notebooks and smart laboratories, to improve the digitization and knowledge management of the scientific record using semantic web technologies; and using IoT devices in the laboratory. She has also worked on a number of interdisciplinary Semantic Web projects in different domains, including agriculture, chemistry and the social sciences. Further details on this event can be found at: https://futurebloodtesting.org/event/03-02-2021-future-blood-testing-network-landscape-report-funding-town-meeting/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/rhvlEi6P8Nk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116735
 
Title Introduction to our Funding Call - Dr Samantha Kanza (University of Reading, University of Southampton). 
Description This video is the second talk from our Landscape Report Funding Call Town Meeting that took place on the 03/02/2022. Introduction to our Funding Call - Dr Samantha Kanza (University of Reading, University of Southampton). Bio: Dr Samantha Kanza is an Enterprise Fellow at the University of Southampton. She completed her MEng in Computer Science at the University of Southampton and then worked for BAE Systems Applied Intelligence for a year before returning to do an iPhD in Web Science (in Computer Science and Chemistry), which focused on Semantic Tagging of Scientific Documents and Electronic Lab Notebooks. She was awarded her PhD in April 2018. Samantha works in the interdisciplinary research area of applying computer science techniques to the scientific domain, specifically through the use of semantic web technologies and artificial intelligence. Her research includes looking at electronic lab notebooks and smart laboratories, to improve the digitization and knowledge management of the scientific record using semantic web technologies; and using IoT devices in the laboratory. She has also worked on a number of interdisciplinary Semantic Web projects in different domains, including agriculture, chemistry and the social sciences. Further details on this event can be found at: https://futurebloodtesting.org/event/03-02-2021-future-blood-testing-network-landscape-report-funding-town-meeting/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/rhvlEi6P8Nk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Landscape Report Funding Call Town Meeting and helped encourage Network Members to apply for our first funding call. 
URL https://zenodo.org/record/7116736
 
Title Introduction to the Future Blood Testing Network Plus - Dr Weizi (Vicky) Li (Henley Business School, University of Reading) 
Description This video is the first talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Introduction - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/YuBsU3NDdB0 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this Network Theme. 
URL https://zenodo.org/record/7115898
 
Title Introduction to the Future Blood Testing Network Plus - Dr Weizi (Vicky) Li (Henley Business School, University of Reading) 
Description This video is the first talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Introduction - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/YuBsU3NDdB0 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7115897
 
Title Landscape of Future blood testing in healthcare practice - Professor Dimitris Grammatopoulos (University of Warwick) 
Description This video is the third talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  Landscape of Future blood testing in healthcare practice - Professor Dimitris Grammatopoulos (University of Warwick).  Bio: Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust, where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick. Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=8tL9FEqIv6o&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=3 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10276990
 
Title Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading) 
Description This video is the third talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading). Bio: Jon Gibbins is Professor of Cell Biology within the School of Biological Sciences at the University and is Director of the Institute for Cardiovascular and Metabolic Research. He is a graduate of the University, obtaining a degree in Pathobiology with Chemistry in 1991 and a PhD in Molecular Endocrinology in 1995. Following a period of postdoctoral research at the Oxford University, he returned to Reading in 1998 as a lecturer. Jon has established an internationally leading research group that studies blood clotting, with a particular focus on the development of more effective clinical strategies for the prevention and treatment of heart attacks and strokes, and thrombosis associated with infection. Jon values greatly working in an active, engaging and successful school, in which all aspects of biology are represented, and he champions cross-disciplinary working to approach today's most challenging and pressing questions in new ways. He believes strongly in widening participation and improving levels of equity, diversity and inclusion across our institution. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/8vJZ_WO-dvk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7116897
 
Title Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading) 
Description This video is the third talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading). Bio: Jon Gibbins is Professor of Cell Biology within the School of Biological Sciences at the University and is Director of the Institute for Cardiovascular and Metabolic Research. He is a graduate of the University, obtaining a degree in Pathobiology with Chemistry in 1991 and a PhD in Molecular Endocrinology in 1995. Following a period of postdoctoral research at the Oxford University, he returned to Reading in 1998 as a lecturer. Jon has established an internationally leading research group that studies blood clotting, with a particular focus on the development of more effective clinical strategies for the prevention and treatment of heart attacks and strokes, and thrombosis associated with infection. Jon values greatly working in an active, engaging and successful school, in which all aspects of biology are represented, and he champions cross-disciplinary working to approach today's most challenging and pressing questions in new ways. He believes strongly in widening participation and improving levels of equity, diversity and inclusion across our institution. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/8vJZ_WO-dvk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116896
 
Title Network Introduction - Dr Weizi (Vicky) Li (Henley Business School, University of Reading) 
Description This video is the first talk from our Landscape Report Funding Call Town Meeting that took place on the 03/02/2022. Network Introduction - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/03-02-2021-future-blood-testing-network-landscape-report-funding-town-meeting/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/I1xsig9C8w0 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116460
 
Title Network Theme: Can blood sampling become a new data source in the role of self-monitoring and self-management of health? - Dr Mark Elliott (University of Warwick) 
Description This video is the fourth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Can blood sampling become a new data source in the role of self-monitoring and self-management of health? - Dr Mark Elliott (University of Warwick) Bio: Dr Mark Elliott Mark is an Associate Professor at the Institute of Digital Healthcare, WMG, University of Warwick (UoW). Mark's core research focuses on human movement and physiology analytics. His research uses signal processing and data science approaches to monitor, measure and model human movement and physiology to infer health status. He is the PI of the WMG Motion Capture Laboratory. His work further extends into the broader area of using wearable and on-the- body sensing devices to make objective measures of human behaviour and behaviour change. Much of Dr Elliott's research is highly applied and involves collaborating with commercial and NHS partners. He has received funding from EPSRC, Innovate UK and SBRI Healthcare, as well as direct industrial funding. He is currently Data Analytics Theme Lead for the EPSRC funded OATech+ Network and on the steering committee for the EPSRC funded VSimulators facilities at Bath and Exeter. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ChdbggScUgo 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116312
 
Title Network Theme: Can blood sampling become a new data source in the role of self-monitoring and self-management of health? - Dr Mark Elliott (University of Warwick) 
Description This video is the fourth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Can blood sampling become a new data source in the role of self-monitoring and self-management of health? - Dr Mark Elliott (University of Warwick) Bio: Dr Mark Elliott Mark is an Associate Professor at the Institute of Digital Healthcare, WMG, University of Warwick (UoW). Mark's core research focuses on human movement and physiology analytics. His research uses signal processing and data science approaches to monitor, measure and model human movement and physiology to infer health status. He is the PI of the WMG Motion Capture Laboratory. His work further extends into the broader area of using wearable and on-the- body sensing devices to make objective measures of human behaviour and behaviour change. Much of Dr Elliott's research is highly applied and involves collaborating with commercial and NHS partners. He has received funding from EPSRC, Innovate UK and SBRI Healthcare, as well as direct industrial funding. He is currently Data Analytics Theme Lead for the EPSRC funded OATech+ Network and on the steering committee for the EPSRC funded VSimulators facilities at Bath and Exeter. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ChdbggScUgo 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this Network Theme. 
URL https://zenodo.org/record/7116313
 
Title Network Theme: Continuous blood processing for patient specific therapies - Dr Robert Barker (University of Kent) 
Description This video is the third talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Continuous blood processing for patient specific therapies - Dr Robert Barker (University of Kent) Bio: Dr Robert Barker is an Associate Professor in Chemistry in the School of Physical Sciences, School Director of Public Engagement, project lead for the 'Future Human' Signature Research, University of Kent (UoK). He is a Royal Society Industrial Fellow and the PI of the trans-disciplinary EPSRC project Optimising Me Manufacturing Systems [EP/R022534/1], exploring continuous blood processing for healthcare and developing a healthcare micro-factory that provides on-the-body manufacturing of therapeutics, continuously and in response to the body's needs. His work focuses on the whole blood processing and the development of a manufacturing system for T-cell immunotherapies which present a cure for some of the most aggressive forms of cancer (acute lymphoblastic leukaemia and chronic lymphoblastic leukaemia). His research is at the interface of industry and the NHS to meet their needs for continuous blood monitoring and to help the shift away from the current one-size-fits-all approach to deliver patient-specific therapies. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/T4UVEOM1cZU 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this Network Theme. 
URL https://zenodo.org/record/7115998
 
Title Network Theme: Digital and data-driven blood monitoring and analytics for patient centred care pathways - Dr Weizi (Vicky) Li (Henley Business School, University of Reading) 
Description This video is the fifth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Digital and data-driven blood monitoring and analytics for patient centred care pathways - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/egINC9hJifI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this Network Theme. 
URL https://zenodo.org/record/7116338
 
Title Network Theme: Digital and data-driven blood monitoring and analytics for patient centred care pathways - Dr Weizi (Vicky) Li (Henley Business School, University of Reading) 
Description This video is the fifth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Digital and data-driven blood monitoring and analytics for patient centred care pathways - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/egINC9hJifI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116337
 
Title Network Theme: Sensor Technologies - Dr Sergiy Korposh (University of Nottingham) 
Description This video is the second talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Sensor Technologies - Dr Sergiy Korposh (University of Nottingham) Bio: Dr Sergiy Korposh is an Associate Professor in Electronics, Nanoscale Bioelectronics and Biophotonics at University of Nottingham. His current research focuses on the development of fibre optic sensors and instrumentation for biomedical application from discovery at the interface with physics and chemistry through to application addressing major healthcare challenges. He has published over 100 (h-index 21) peer-reviewed journal and conference papers, book contributions, holds 11 patents (4 licensed to UK and Japanese companies) and given invited presentations at international meetings in the field of optical fibre chemical sensors. He has managed as a PI and Co-I a total funding portfolio of £3.5 million in the area of biomedical point of care sensors. He was a Director of the EPSRC funded Network Cyclops (EP/N026985/1, Closed Loop Control Systems for Optimising Treatment, http://www.healthcaretechnologies.ac.uk/cyclops/); with the aim to facilitate the formation of a community of academics, clinicians and industrialists, across multiple disciplines (photonic sensing, advanced materials, treatment, and mathematical modelling), including international collaborators to address grand challenges in automation of treatment in healthcare. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/tv0JydXOdUI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this Network Theme. 
URL https://zenodo.org/record/6602357
 
Title Network Theme: Sensor Technologies - Dr Sergiy Korposh (University of Nottingham) 
Description This video is the second talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: Sensor Technologies - Dr Sergiy Korposh (University of Nottingham) Bio: Dr Sergiy Korposh is an Associate Professor in Electronics, Nanoscale Bioelectronics and Biophotonics at University of Nottingham. His current research focuses on the development of fibre optic sensors and instrumentation for biomedical application from discovery at the interface with physics and chemistry through to application addressing major healthcare challenges. He has published over 100 (h-index 21) peer-reviewed journal and conference papers, book contributions, holds 11 patents (4 licensed to UK and Japanese companies) and given invited presentations at international meetings in the field of optical fibre chemical sensors. He has managed as a PI and Co-I a total funding portfolio of £3.5 million in the area of biomedical point of care sensors. He was a Director of the EPSRC funded Network Cyclops (EP/N026985/1, Closed Loop Control Systems for Optimising Treatment, http://www.healthcaretechnologies.ac.uk/cyclops/); with the aim to facilitate the formation of a community of academics, clinicians and industrialists, across multiple disciplines (photonic sensing, advanced materials, treatment, and mathematical modelling), including international collaborators to address grand challenges in automation of treatment in healthcare. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/tv0JydXOdUI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/6602356
 
Title Network Theme: The potential of machine learning and AI for blood based investigations - Professor Jeremy Frey (University of Southampton) 
Description This video is the sixth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Network Theme: The potential of machine learning and AI for blood based investigations - Professor Jeremy Frey (University of Southampton) Bio: Prof Jeremy Frey Professor of Physical Chemistry, Head of Computational Systems Chemistry, University of Southampton (UoS). He is PI of AI for Scientific Discovery Network+, and co_I on the Internet of Food Things Digital Economy Network+ and has had considerable involvement in the UK e-Science and Digital Economy programmes for many years (e.g., PI of the Digital Economy IT as a Utility Network+. He is a strong proponent of interdisciplinary research and the use of digital technology and ideas to enhance methods of scientific research & development. His own research involves activities across the physical land life sciences, from the application of novel mathematical analysis (e.g., Topological Data Analysis), laser spectroscopy and imagining techniques to chemical and biological problems, with the development of sensors and imagining systems such as the novel soft x-ray microscope. In parallel he works on the integration of these techniques with full provenance environment into laboratory systems using semantic web technologies. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/eNORwfMy5cE 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116350
 
Title Precision Health and AI: improving health for everyone - Arjun Panesar (DDM Health) 
Description This video is the twelfth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. Precision Health and AI: improving health for everyone - Arjun Panesar (DDM Health) Bio: Arjun Panesar is the founder of DDM Health, providers of clinically-validated digital health solutions to over 1.8 million people. Benefiting from almost two decades of experience in big data, AI and AI ethics, Arjun leads the development of evidence-based digital innovations that harness the power of machine learning to provide precision medicine to patients, health services, and governments. Arjun's work has received international recognition featuring in the Forbes, New Scientist, BBC and The Times. Arjun is a best-selling author on the topics of healthcare and AI, authoring two editions of Machine Learning and AI in Healthcare, and contributing to Handbook of Global Health, a major reference work. Arjun is an advisor to the Information School, University of Sheffield, Fellow to the NHS Innovation Accelerator, visiting lecturer at University of Warwick Medical School, and was recognised by Imperial College as an Alumni Leader for his contribution and impact to society. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/clPmdeLP5_E 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7117234
 
Title Precision Health and AI: improving health for everyone - Arjun Panesar (DDM Health) 
Description This video is the twelfth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022. Precision Health and AI: improving health for everyone - Arjun Panesar (DDM Health) Bio: Arjun Panesar is the founder of DDM Health, providers of clinically-validated digital health solutions to over 1.8 million people. Benefiting from almost two decades of experience in big data, AI and AI ethics, Arjun leads the development of evidence-based digital innovations that harness the power of machine learning to provide precision medicine to patients, health services, and governments. Arjun's work has received international recognition featuring in the Forbes, New Scientist, BBC and The Times. Arjun is a best-selling author on the topics of healthcare and AI, authoring two editions of Machine Learning and AI in Healthcare, and contributing to Handbook of Global Health, a major reference work. Arjun is an advisor to the Information School, University of Sheffield, Fellow to the NHS Innovation Accelerator, visiting lecturer at University of Warwick Medical School, and was recognised by Imperial College as an Alumni Leader for his contribution and impact to society. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/clPmdeLP5_E 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7117235
 
Title Raman spectroscopy for remote blood testing - Dr Donna Arnold (University of Kent) 
Description This video is the eighth talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  Raman spectroscopy for remote blood testing - Dr Donna Arnold (University of Kent). Bio: Donna Arnold is a materials scientist with broad interests in using diffraction techniques and Raman spectroscopy to study Materials. Donna was awarded her PhD in 2004 having worked on the electronic properties of porous manganese oxides at the Royal Institution of Great Britain and University College London. After completing postdoctoral positions at Foundation of Research and Technology - Hellas (FORTH) in Crete, University College Cork, Ireland and University of St Andrews, UK she was appointed to an academic position at the University of Kent in 2010 where she is currently Reader of Chemistry and Forensic Science. Recently her work has diversified from the characterisation to explore how techniques such as Raman can be utilised in forensic science, cultural heritage and sports doping  Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=-r6T5NznGmk&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=6 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10277227
 
Title Remote Immune Monitoring: Need, Opportunities and Challenges - Professor Kourosh Saeb-Parsy (University of Cambridge & Cambridge University Hospitals NHS Foundation Trust) 
Description This video is the seventh talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Remote Immune Monitoring: Need, Opportunities and Challenges - Professor Kourosh Saeb-Parsy (University of Cambridge & Cambridge University Hospitals NHS Foundation Trust) Bio: Professor Kelvin Tsoi is an Epidemiologist specialized in Digital Health. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence-based medicine and population cohort studies. He obtained his Bachler Degree from Department of Statistics and Doctor of Philosophy from School of Public Health in the Chinese University of Hong Kong. He further received post-doctoral training in the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics. He was also appointed as a Director of CUHK JC Bowel Cancer Education Centre to promote colorectal cancer screening. In 2011, he worked as a research scientist in Hospital Authority. He led projects covering a wide range of service areas on chronic diseases, such as service demand projection for schizophrenia and dementia. The experience of database management enhanced his understanding of the HA database structures. In 2013, he was invited to join the interdisciplinary team for Big Data research and worked closely with a team of engineers and data scientists. Currently, Professor Tsoi is an Associate Professor in JC School of Public Health and Primary Care, SH big Data Decision Analytics Research Centre and JC Institute of Ageing. I matriculated as a medical student at Fitzwilliam College in 1993. My interest in biomedical research was developed during my Part II year studying Anatomy A (neurosciences and developmental biology) and I subsequently enrolled on the MB-PhD programme. I completed my doctoral thesis in neurophysiology of circadian rhythms in 2000 and qualified as a medical doctor in 2001. While studying for my PhD, I pursued an active interest in teaching and started supervising undergraduates at Fitzwilliam (and other colleges) in 1998. I served as MCR President in 1999, became a Fellow in 2003 and Director of Studies in Clinical Medicine in 2004. I pursued a career in surgery after graduation and was appointed as a University Lecturer in Transplant Surgery in 2012. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ANZKGxj87E0 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116395
 
Title Remote Immune Monitoring: Need, Opportunities and Challenges - Professor Kourosh Saeb-Parsy (University of Cambridge & Cambridge University Hospitals NHS Foundation Trust) 
Description This video is the seventh talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. Remote Immune Monitoring: Need, Opportunities and Challenges - Professor Kourosh Saeb-Parsy (University of Cambridge & Cambridge University Hospitals NHS Foundation Trust) Bio: Professor Kelvin Tsoi is an Epidemiologist specialized in Digital Health. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence-based medicine and population cohort studies. He obtained his Bachler Degree from Department of Statistics and Doctor of Philosophy from School of Public Health in the Chinese University of Hong Kong. He further received post-doctoral training in the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics. He was also appointed as a Director of CUHK JC Bowel Cancer Education Centre to promote colorectal cancer screening. In 2011, he worked as a research scientist in Hospital Authority. He led projects covering a wide range of service areas on chronic diseases, such as service demand projection for schizophrenia and dementia. The experience of database management enhanced his understanding of the HA database structures. In 2013, he was invited to join the interdisciplinary team for Big Data research and worked closely with a team of engineers and data scientists. Currently, Professor Tsoi is an Associate Professor in JC School of Public Health and Primary Care, SH big Data Decision Analytics Research Centre and JC Institute of Ageing. I matriculated as a medical student at Fitzwilliam College in 1993. My interest in biomedical research was developed during my Part II year studying Anatomy A (neurosciences and developmental biology) and I subsequently enrolled on the MB-PhD programme. I completed my doctoral thesis in neurophysiology of circadian rhythms in 2000 and qualified as a medical doctor in 2001. While studying for my PhD, I pursued an active interest in teaching and started supervising undergraduates at Fitzwilliam (and other colleges) in 1998. I served as MCR President in 1999, became a Fellow in 2003 and Director of Studies in Clinical Medicine in 2004. I pursued a career in surgery after graduation and was appointed as a University Lecturer in Transplant Surgery in 2012. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ANZKGxj87E0 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this research topic. 
URL https://zenodo.org/record/7116396
 
Title Remote Testing & AI - What's Coming Next - Mr Frank Khan Sullivan 
Description This video is the second talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2022.  Remote Testing & AI - What's Coming Next - Mr Frank Khan Sullivan (Enhanced Fertility).  Bio: Frank Khan Sullivan is the CTO of Enhanced Fertility, a Europe-wide remote blood testing and diagnostics business dedicated to helping patients struggling to conceive start a family. He is serves as Co-Founder and lead technologist for the business, incorporating best practices from data analytics, AI/ML and clinical diagnostics to deliver a better patient experience and outcomes that matter. Frank has 15 years' experience working in the technology and HealthTech space, having sold his stake in a previous diagnostics business and working as CSO - Data for Publicis Groupe. In 2020 he co-founded Enhanced Fertility with his wife and CEO, who was diagnosed with infertility at a young age, to alleviate the suffering of other patients just like them by innovating in remote blood testing, decentralised diagnostics and using AI to speed up time to diagnosis. He currently resides in London and Lisbon. You can connect with him on LinkedIn. Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=85UfW_ESpqE&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=2 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10276876
 
Title Remote blood monitoring for cancer patients- a preliminary landscape analysis - Beth Harvey (University of Reading) 
Description This video is the fifth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Remote blood monitoring for cancer patients- a preliminary landscape analysis - Beth Harvey (University of Reading) Bio: Beth Harvey is currently a master's student in digital health and data analytics at the Henley Business School. Having completed her bachelor's in biomedical science, Beth has then gone on to work in the medical device and IVD regulatory sector with a consultancy firm in Vancouver. After moving back to the UK in 2019 Beth worked with multiple UK manufacturers in the digital health space which spurred her interest in the field she is now studying. Beth's research interests are in healthcare innovation remote patient monitoring, and data analysis. She is currently finishing her dissertation on the opportunities and challenges for remote blood monitoring in oncology in collaboration with the Future Blood Network. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/8pbO3N9IQKM 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7116950
 
Title Remote blood monitoring for cancer patients- a preliminary landscape analysis - Beth Harvey (University of Reading) 
Description This video is the fifth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Remote blood monitoring for cancer patients- a preliminary landscape analysis - Beth Harvey (University of Reading) Bio: Beth Harvey is currently a master's student in digital health and data analytics at the Henley Business School. Having completed her bachelor's in biomedical science, Beth has then gone on to work in the medical device and IVD regulatory sector with a consultancy firm in Vancouver. After moving back to the UK in 2019 Beth worked with multiple UK manufacturers in the digital health space which spurred her interest in the field she is now studying. Beth's research interests are in healthcare innovation remote patient monitoring, and data analysis. She is currently finishing her dissertation on the opportunities and challenges for remote blood monitoring in oncology in collaboration with the Future Blood Network. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/8pbO3N9IQKM 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116949
 
Title The Application of Machine Learning for Classification on Blood Pressure Variability. A New Approach for an Old Idea - Professor Kelvin Tsoi (The Chinese University of Hong Kong, School of Public Health and Primary Care) 
Description This video is the eighth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. The Application of Machine Learning for Classification on Blood Pressure Variability. A New Approach for an Old Idea - Professor Kelvin Tsoi (The Chinese University of Hong Kong, School of Public Health and Primary Care) Bio: Professor Kelvin Tsoi is an Epidemiologist specialized in Digital Health. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence-based medicine and population cohort studies. He obtained his Bachler Degree from Department of Statistics and Doctor of Philosophy from School of Public Health in the Chinese University of Hong Kong. He further received post-doctoral training in the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics. He was also appointed as a Director of CUHK JC Bowel Cancer Education Centre to promote colorectal cancer screening. In 2011, he worked as a research scientist in Hospital Authority. He led projects covering a wide range of service areas on chronic diseases, such as service demand projection for schizophrenia and dementia. The experience of database management enhanced his understanding of the HA database structures. In 2013, he was invited to join the interdisciplinary team for Big Data research and worked closely with a team of engineers and data scientists. Currently, Professor Tsoi is an Associate Professor in JC School of Public Health and Primary Care, SH big Data Decision Analytics Research Centre and JC Institute of Ageing. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/liLVKA-JHiI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact This video is an output from the Future Blood Testing Network. It was presented at our Launch event and helped bring on board new members who were interested in this research topic. 
URL https://zenodo.org/record/7116410
 
Title The Application of Machine Learning for Classification on Blood Pressure Variability. A New Approach for an Old Idea - Professor Kelvin Tsoi (The Chinese University of Hong Kong, School of Public Health and Primary Care) 
Description This video is the eighth talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021. The Application of Machine Learning for Classification on Blood Pressure Variability. A New Approach for an Old Idea - Professor Kelvin Tsoi (The Chinese University of Hong Kong, School of Public Health and Primary Care) Bio: Professor Kelvin Tsoi is an Epidemiologist specialized in Digital Health. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence-based medicine and population cohort studies. He obtained his Bachler Degree from Department of Statistics and Doctor of Philosophy from School of Public Health in the Chinese University of Hong Kong. He further received post-doctoral training in the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics. He was also appointed as a Director of CUHK JC Bowel Cancer Education Centre to promote colorectal cancer screening. In 2011, he worked as a research scientist in Hospital Authority. He led projects covering a wide range of service areas on chronic diseases, such as service demand projection for schizophrenia and dementia. The experience of database management enhanced his understanding of the HA database structures. In 2013, he was invited to join the interdisciplinary team for Big Data research and worked closely with a team of engineers and data scientists. Currently, Professor Tsoi is an Associate Professor in JC School of Public Health and Primary Care, SH big Data Decision Analytics Research Centre and JC Institute of Ageing. Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/liLVKA-JHiI 
Type Of Art Film/Video/Animation 
Year Produced 2021 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116409
 
Title Transforming the UK's diagnostics agenda after COVID-19 and grand challenges - Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick) 
Description This video is the second talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Transforming the UK's diagnostics agenda after COVID-19 and grand challenges - Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick) Bio: Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust. where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/HiOlRzJPR7Q 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7116848
 
Title Transforming the UK's diagnostics agenda after COVID-19 and grand challenges - Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick) 
Description This video is the second talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Transforming the UK's diagnostics agenda after COVID-19 and grand challenges - Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick) Bio: Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust. where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/HiOlRzJPR7Q 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7116849
 
Title Translating blood tests from the Academic Lab into Clinical Setting a Case Study - Dr Martin Peacock 
Description This video is the eleventh talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023.  Translating blood tests from the Academic Lab into the Clinical Setting - a Case Study - Dr Martin Peacock (Zimmer and Peacock Ltd).  Bio: Martin Peacock is a Director at Zimmer and Peacock Ltd, a company that sees sensors as a critical part of various social and commercial revolutions, such as the Internet of Things (IoT), Sensor Web, and the Invitro Diagnostics Market (IVD). With over eight years of experience in this role, He leads a team of talented scientists and engineers who partner with academia and industry to develop and manufacture innovative sensors and medical diagnostics. His core competencies include biosensor design and fabrication, biotechnology research and development, IP generation, scalable manufacturing, and customer-specific applications. He is also an Honorary Senior Lecturer (Science) at Swansea University, where he shares his knowledge and expertise in biosensors and biotechnology with students and researchers. Additionally, he is a Director at ALIKSIR LTD and CeeLab, two companies that focus on the interface between surfaces and biology, and cloud-based video conferencing solutions, respectively. His mission is to create and deliver cutting-edge solutions that address the needs and challenges of various markets and sectors, and to foster collaboration and innovation across the globe  Further details on this event can be found at: https://futurebloodtesting.org/event/the-future-of-healthcare-remote-blood-testing-monitoring-ai/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://www.youtube.com/watch?v=lI2YeTpmQ40&list=PL_5Zbof1GNkCZLgQwZnxsMTQUELUCQHlp?dex=8 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/doi/10.5281/zenodo.10277350
 
Title Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University) 
Description This video is the seventh talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University) Bio: Bryant Lin, MD, MEng is a primary care physician, educator and researcher. The cornerstone of Dr. Lin's work is keeping medicine focused on humans - patients, providers, families and trainees - and not lost in technology and algorithms. His research and educational interests span (1) Developing and testing novel medical technologies, (2) Improving the health of Asian populations with Precision and Population Health, and (3) Increasing expression and interconnections in the Health Community with the Humanities and Arts. After receiving his undergraduate and master's degrees in Electrical Engineering and Computer Science from MIT, he completed his MD and internal Medicine training at Tufts University School of Medicine and Tufts Medical Center. He came to Stanford to serve as a Research Fellow in Cardiac Electrophysiology and Biodesign Fellow where he learned to identify unmet human-centered needs. Since completing his post-graduate training, he stayed at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine where he has invented and researched new medical technologies addressing unmet human-centered needs and started the Consultative Medicine Clinic evaluating patients with medical mysteries. He serves as the Training Director for the Joe and Linda Chlapaty DECIDE Center which has created a novel shared decision making tool for atrial fibrillation anticoagulation and is an investigator in several active clinical trials. Three years ago, he co-founded and currently co-directs, with Dr. Latha Palaniappan, the Center for Asian Health Research and Education (CARE) which aims to improve the health of Asians everywhere. Most recently, he has worked closely with the Medicine and the Muse leadership to help start the Stuck@Home concert series, the Stanford SoundWalk and the COVID Remembrance project. Dr. Lin has an active interest in storytelling and film-making. He co-directs an undergraduate seminar, MED 53Q "Storytelling in Medicine", with Dr. Lauren Edwards and is working with a group of students on a documentary on end-of-life care at a JapaneseAmerican Senior Home in the Bay Area. Kevin Chang MD, MS, is a primary care physician. His focus in on patient care, population health and quality improvement, and medical education. He received his undergraduate degree and master's degree in biomedical engineering from Duke University and Stanford University respectively, and completed his MD at New York University, followed by his medical training at Stanford University. He has since stayed on at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine, where he also serves as the co-director of the resident physician Internal Medicine clinic. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ozk1iJYC1yk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact About 100 participants, both in person and online, attended the presentation, including clinicians, patients, and academics. 
URL https://zenodo.org/record/7117135
 
Title Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University) 
Description This video is the seventh talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022. Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University) Bio: Bryant Lin, MD, MEng is a primary care physician, educator and researcher. The cornerstone of Dr. Lin's work is keeping medicine focused on humans - patients, providers, families and trainees - and not lost in technology and algorithms. His research and educational interests span (1) Developing and testing novel medical technologies, (2) Improving the health of Asian populations with Precision and Population Health, and (3) Increasing expression and interconnections in the Health Community with the Humanities and Arts. After receiving his undergraduate and master's degrees in Electrical Engineering and Computer Science from MIT, he completed his MD and internal Medicine training at Tufts University School of Medicine and Tufts Medical Center. He came to Stanford to serve as a Research Fellow in Cardiac Electrophysiology and Biodesign Fellow where he learned to identify unmet human-centered needs. Since completing his post-graduate training, he stayed at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine where he has invented and researched new medical technologies addressing unmet human-centered needs and started the Consultative Medicine Clinic evaluating patients with medical mysteries. He serves as the Training Director for the Joe and Linda Chlapaty DECIDE Center which has created a novel shared decision making tool for atrial fibrillation anticoagulation and is an investigator in several active clinical trials. Three years ago, he co-founded and currently co-directs, with Dr. Latha Palaniappan, the Center for Asian Health Research and Education (CARE) which aims to improve the health of Asians everywhere. Most recently, he has worked closely with the Medicine and the Muse leadership to help start the Stuck@Home concert series, the Stanford SoundWalk and the COVID Remembrance project. Dr. Lin has an active interest in storytelling and film-making. He co-directs an undergraduate seminar, MED 53Q "Storytelling in Medicine", with Dr. Lauren Edwards and is working with a group of students on a documentary on end-of-life care at a JapaneseAmerican Senior Home in the Bay Area. Kevin Chang MD, MS, is a primary care physician. His focus in on patient care, population health and quality improvement, and medical education. He received his undergraduate degree and master's degree in biomedical engineering from Duke University and Stanford University respectively, and completed his MD at New York University, followed by his medical training at Stanford University. He has since stayed on at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine, where he also serves as the co-director of the resident physician Internal Medicine clinic. Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/ This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 YouTube Link: https://youtu.be/ozk1iJYC1yk 
Type Of Art Film/Video/Animation 
Year Produced 2022 
Impact This video showcases our conference which brought a diverse set of community members together to discuss the research challenges and opportunities of future blood testing. 
URL https://zenodo.org/record/7117136
 
Description New lab-based methods were developed for the identification and separation of T-Cells in flow environments, potentially enabling in the future the separation, detection and capture of these cells in a more dynamic and realtime environment than is currently possible. Additionally, new methods were developed to study, at sub-nanometer level, the interactions that occur between biological material and the surface of medical devices, such as these being developed here, under the continuous flow and confinement conditions that are experienced at the surface of these devices. These methods will be able to provide structural insight into these interactions in real biological conditions that will directly impact the design, optimisation and development of new medical devices and provide better understanding of the biology-material interface to develop and engineer new materials for bio-engineering purposes. Further, sector insights allowed the development of a new proposed decentralised business approach for this sector and supported the development of new bioreactor designs.
Exploitation Route The outcomes of this work have potential for impact in the future of healthcare, with more research by academic and industrial partners there is real potential to move towards the decentralised manufacturing of therapies and ultimately (after full consideration of regulatory barriers) towards wearable body or blood-integrated healthcare devices. There is also potential for this impact in other non-healthcare sectors, namely the agri-tech sector, bio-refineries for waste reprocessing and in security settings.
Sectors Agriculture

Food and Drink

Chemicals

Electronics

Environment

Healthcare

Manufacturing

including Industrial Biotechology

Pharmaceuticals and Medical Biotechnology

Security and Diplomacy

 
Description The ideas and direction of research developed in this project have lead to closer ties with the NHS and industrial sector, particularly in the area of continuous and remote blood monitoring, a key technological challenges that started to be addressed through this research. This has lead to the creation of the Future Blood Testing for Inclusive Monitoring and Personalised Analytics Network (funded by the EPSRC - EP/W000652/1), through the network (some key contacts from which were first developed during this funded project on which we are reporting) we are bringing together key stakeholders required to enable patients to have access to efficient, timely and cost-effective blood pathology services and co-creating a roadmap for the future of this area. Since establishing this, the following impacts have been realised: 1. New knowledge is generated on the landscape of the current and future of blood testing. Findings from the landscape report were gathered through a literature review and interviews with key stakeholders on the future and the roadmap of blood testing. The following new findings have been discovered: • The strength of the diagnostics regulation, areas for improvement, recommendations and opportunities have been identified. • The current state of the art of diagnostic services in the UK. An overview analysis has been conducted with findings including: 1) key developments over the past 20+ years that shaped the current landscape; 2) the modernisation agenda, service reconfiguration and the Carter review; 3) the need for change: pathology networks to improve efficiencies. • Recommendations on the UK diagnostic landscape reform and future blood testing are being developed, covering strategy, planning and future roles, structure, modernisation, and partner collaboration. 2. New technology is being developed in the blood monitoring and AI analysis space. 3. New international consortium on virtual ward and remote blood monitoring. A UK-Canada-Hong Kong consortium is developed with the International Society of Digital Health. Further, translation of the key underpinning research is currently being translated for use in the agri-tech sector, particularly working with industrial partners in the development of bio-refineries for the reprocessing and re-valorisation of agri-waste, supporting the sector transition towards circular systems and food security.
First Year Of Impact 2022
Sector Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology
Impact Types Societal

Policy & public services

 
Description Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital (AIDPATH)
Amount € 9,860,991 (EUR)
Funding ID 101016909 
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 01/2021 
End 12/2024
 
Description Development of a stability and preservation strategy for NKT cells - Collaborate to Innovate round 2: Advanced Therapies
Amount £99,998 (GBP)
Organisation MedCity 
Sector Public
Country United Kingdom
Start 08/2019 
End 08/2020
 
Description Farming Innovation Pathways (FIP) - Industrial Research
Amount £547,110 (GBP)
Funding ID 10006133 
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 08/2021 
End 09/2023
 
Description Future blood testing for inclusive monitoring and personalised analytics Network+
Amount £800,898 (GBP)
Funding ID EP/W000652/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 09/2021 
End 09/2025
 
Description Global Challenges Doctoral Centre
Amount £72,000 (GBP)
Organisation University of Kent 
Sector Academic/University
Country United Kingdom
Start 08/2019 
End 03/2023
 
Description Global Challenges Doctoral Centre
Amount £72,000 (GBP)
Organisation University of Kent 
Sector Academic/University
Country United Kingdom
Start 08/2020 
End 03/2024
 
Description Global Challenges Doctoral Centre
Amount £129,000 (GBP)
Organisation University of Kent 
Sector Academic/University
Country United Kingdom
Start 08/2021 
End 03/2025
 
Description Growing Kent and Medway: Collaborative Research and Development
Amount £215,553 (GBP)
Funding ID 10022337 
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 02/2022 
End 08/2024
 
Description InnovateUK KTP with Aber Instruments - Development of a Biocapacitance Probe for Real-Time, Online ATMP Analytics
Amount £232,720 (GBP)
Funding ID Ref No: KTP 12049 
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 05/2020 
End 05/2022
 
Description MRC IAA 2021 University of Kent
Amount £357,000 (GBP)
Funding ID MR/X502753/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2022 
End 03/2025
 
Description Royal Commission Industrial Studentship: Development of experimentally-integrated process models for adaptive CAR-T cell therapy manufacturing
Amount £94,000 (GBP)
Organisation Royal Commission for the Exhibition of 1851 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2019 
End 09/2022
 
Description Short Industrial Fellowship & Industrial Summer Studentship
Amount £24,226 (GBP)
Organisation The Royal Society 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2018 
End 11/2019
 
Description The Kent Mycoprotein Hub
Amount £94,120 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 09/2023 
End 03/2024
 
Description UK Community Renewal Fund: Net Zero Pathway for Change
Amount £638,115 (GBP)
Organisation Ministry of Housing, Communities and Local Government 
Sector Public
Country United Kingdom
Start 12/2021 
End 12/2022
 
Description Bath Mechanical Engineering year 3 project students 
Organisation University of Bath
Department Department of Mechanical Engineering
Country United Kingdom 
Sector Academic/University 
PI Contribution I supervised a team of Mechanical engineering 3rd year undergraduate students who undertook their third year project working on the OMMS project. I had regular meetings with them to help guide their work over the course of the year. We had regular presentation and tutorial sessions. I shared our process maps and some insight into the project.
Collaborator Contribution The team focused on the engineering overview. They analysed other similar devices which were being moved 'on body' e.g. diabetes and blood transfusion. They provided a timeline for funding need against device development. Their analysis suggested a larger interim device on a stand would help generate funding to allow for the final on body device to be realised. The group gave interim reports and a final report as a group. They provided designs for the first prototype of the OMMS static device (OSD). For their course they also made individual reports that included: - box design reports for gene selection, cell selection, and leukapheresis (what might the device look like in terms of size, weight, packaging - without insight into deeper internal technology) - OMMS static device analysis - OMMS electrical design - OMMS wearable device analysis
Impact Reports included: -Group overview report - Group final presentation - Group poster presentation as part of public design day Individual student reports: - box design reports for gene selection, cell selection, and leukapheresis (what might the device look like in terms of size, weight, packaging - without insight into deeper internal technology) - OMMS static device analysis - OMMS electrical design - OMMS wearable device analysis
Start Year 2018
 
Description Collaboration with Dr Phillip Davies, University of Reading 
Organisation University of Reading
Department Henley Business School
Country United Kingdom 
Sector Academic/University 
PI Contribution I have briefed Dr Davies on the project and engaged him in the broader ideas. We have visited Kent University to meet the team and discuss engagement further. We have worked together to produce a paper on additive manufacture and systems theory in his domain of military defense in order to transfer the knowledge into our domain of the OMMS project. I am providing my knowledge on service and servitization as the broader system forms part of a service.
Collaborator Contribution Dr Davies brings great expertise in general modular systems theory. The construct will be useful in helping ensure we retain modularity of the product as we develop it, as later upgrades of modules is simpler and cheaper if we maintain separation and avoid close coupling of the modules.
Impact This collaboration bridges business and systems engineering, as well as involving additive manufacture. To date with have produced conference paper for Spain Servitization conference and a paper for PPC on his work. We are now developing the paper for OMMS that shows how system design may follow systems theory. If the partnership develops as we hope we will contract for confidentiality as part of the collaboration accordingly.
Start Year 2019
 
Description Collaboration with Sartorius for CAR-T manufacture 
Organisation Sartorius
Country Germany 
Sector Private 
PI Contribution We have established a CAR-T manufacturing process that works for the ambr250 and the Rocking Motion Bioreactor. This has led to publications and webinars hosted by Sartorius promoting the work. We have demonstrated successful expansion and subsequent isolation and characterisation of functionally-effective CAR-T cells using the Sartorius platforms.
Collaborator Contribution Provision of the ambr250 system with perfusion capability and the Rocking Motion bioreactor platform. This also includes all associated consumables to run the systems.
Impact 2 x Publications in Biotechnology and Bioengineering and Biotechnology Journal 2 x Webinars 3 x Conference Presentations
Start Year 2019
 
Description MSc Student team at Bath University 
Organisation University of Bath
Department Department of Mechanical Engineering
Country United Kingdom 
Sector Academic/University 
PI Contribution I supervised a team of 5 MSc Engineering Business Management students from Mechanical Engineering at Bath University to undertake research into the business model for OMMS. The team built upon the work I had done, that of the previous BSc team at Bath and input from the main project. They also signed the NDA to be part of our consorita. I met with them weekly and helped provide supervision of their projects.
Collaborator Contribution The team provided insight into the OMMS business model. They developed Product Development Scenarios, which they then took through Scenario evaluation. They provided a report on Business Model Analysis and finally a set of recommendations on how the OMMS project may best proceed. Each member had an individual project that included specific inputs to the business model work. The team generated reports, that include: -Evaluation of market requirement -Ethical Considerations for OMMS CAR-T Therapy Device -Medical Device Regulation and other applicable regulatory constraints -Effects of changing the production volume on the business -Acceptance of new technology in the medical health care industry
Impact For their MSc assessment they had to produce a group report and presentation on the OMMS business model, plus individual reports: -Evaluation of market requirement -Ethical Considerations for OMMS CAR-T Therapy Device -Medical Device Regulation and other applicable regulatory constraints -Effects of changing the production volume on the business -Acceptance of new technology in the medical health care industry Copies of all their work was given to us. It was also marked. Worked covered business and engineering
Start Year 2019
 
Description BioMedEng19 Conference - Poster 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Industry/Business
Results and Impact Presentation and significant discussion at large National/International conference in Biomedical Engineering.
Year(s) Of Engagement Activity 2019
URL https://www.biomedeng19.com/
 
Description BioProNET 6th Annual Science Meeting - Poster 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Industry/Business
Results and Impact Presentation and discussion entitled "Development of an electrochemical microfluidic platform for gene delivery" to industry professionals and academics. Sparked considerable interest and follow up discussion in the OMMS project.
Year(s) Of Engagement Activity 2019
URL http://biopronetuk.org/6th-annual-science-meeting/
 
Description CRUK-AACR 2019 Joint Conference - Poster 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact Widening discussion at a focused international research conference on the benefits of combining physical sciences with cancer research. Considerable interest and discussions sparked.
Year(s) Of Engagement Activity 2019
URL https://www.cancerresearchuk.org/funding-for-researchers/research-events-and-conferences/cruk-aacr-j...
 
Description FASS Festival of Research - Keynote Speaker - 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact This was a talk done "live" over Zoom to close the 2021 Faculty of Social Science Festival of Science. I spoke about the importance of collaboration, giving an overview of my projects.

A copy of the talk is available here https://youtu.be/azJqb8kCQK8
Year(s) Of Engagement Activity 2021
URL https://issuu.com/universityofsurrey/docs/fass_festival_of_research_programme_2021
 
Description Innovation Bootcamp 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Industry/Business
Results and Impact Developed and delivered a yearly Innovation-focussed event to support networking and engagement between the University and local businesses, including training to support University PG students and staff to prepare to spin-out their research. Networking events involved quick-fire sharing of research and building new collaborative networks. This has now become a yearly event.
Year(s) Of Engagement Activity 2022,2023
 
Description International Conference on Neutron Scattering 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact Presentation about EPSRC funded research and advertising EPSRC funded network at an international subject-specific research conference.
Year(s) Of Engagement Activity 2022
 
Description Involvement in Discussion on the Future of Digital Healthcare 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Industry/Business
Results and Impact Open presentation/contribution to delegate discussion about the future of healthcare technology as part of the Two's company: The What, Why's and How's of Digital Twins in Industry Today & Tomorrow event at the Discovery Park in Sandwich. Significant follow up interest and request to use the project as a case study.
Year(s) Of Engagement Activity 2020
URL https://discovery-park.co.uk/events/twos-company-the-what-whys-and-hows-of-digital-twins-in-industry...
 
Description Keynote at Eastern Arc Conference 2023 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Third sector organisations
Results and Impact Opening Keynote to set to the tone for the Eastern Arc: Food in a Time of Crisis conference.
Year(s) Of Engagement Activity 2023
URL https://easternarc.ac.uk/eastern-arc-conference-2023-food-in-a-time-of-crisis/
 
Description Measuring Cancer Earlier Partnership Workshop 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Industry/Business
Results and Impact Invited to participate in this partnership building workshop.
Year(s) Of Engagement Activity 2021
 
Description Newton-Bhabha UK-India Researcher Links Workshop on New Electrochemical Technologies - Presentation 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact Presentation entitled "Development of an on-the-body cancer immunotherapy device" at The Indian Institute of Science Education and Research (IISER) Pune - IISER Pune (Pune, India) as part of an invited delegation to the Newton-Bhabha UK-India Researcher Links Workshop on New Electrochemical Technologies for Sustainable Fuels, Chemicals and Industrial Processes. Significant follow up interest came from attending the workshop, highlighting us as leaders in microfluidic electroporation amongst a strong international field of electrochemists.
Year(s) Of Engagement Activity 2019
URL http://www.chem.gla.ac.uk/Electrotech2019/
 
Description Presentation at 8th International Conference on Business Servitization, 21-22 November, San Sebastian, Spain 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other audiences
Results and Impact This is work that I supported, following on from the DROPS project where I met the lead author. We discussed how data management makes part of a modular system and have begun collaboration. This is the first output based on Dr Davies work.
The theory has implications for the EPSRC DROPS, OMMS and Transdisciplinary Design Engineering project.
Year(s) Of Engagement Activity 2019
URL https://epubs.surrey.ac.uk/853861/
 
Description Presentation to BEng. 3rd year researchers at University of Bath 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Undergraduate students
Results and Impact I have engaged with BEng. researchers at Bath University department of Mechanical Engineering. A group of around 10 students has to undertake a project and they will take forward part of the OMMS work with me. I gave them a brief overview of the ideas of the project. They will now examine possible device cost, manufacturing methods, location on body etc. This is as part of a group project work that counts towards their degrees.
Year(s) Of Engagement Activity 2019
 
Description Presentation to MSc researchers at University of Bath 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Postgraduate students
Results and Impact I have engaged with MSc Engineering Management student researchers at Bath University department of Mechanical Engineering. A group of around 5 students has to undertake a project that forms 30% of their final mark. They will take forward part of the OMMS work with me. I gave them a brief overview of the ideas of the project. They will now examine medical device regulation, cost modelling, and manufacturing strategy (centralised, decentralised or on-body manufacturing) and associated cost/benefit and risks.
Year(s) Of Engagement Activity 2019
 
Description Presentation to UWE Healthy Ageing Research Group 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact UWE Healthy Ageing group brings together cross faculty researchers to discuss health projects in UWE. At this event were health and life sciences, computer science, robotics, business and engineering staff, post-doctoral fellows and PhD students. I presented a project overview to show the thinking of the OMMS project. This sparked questions and discussions. The concept of moving manufacture was of interest and how the concept may be applied within the ageing population.
Year(s) Of Engagement Activity 2019
 
Description Schools Engagement through South East STEM Hub and IET Christmas Public Lecture 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Invited to deliver all day event engaging with school children about trans-disciplinary research and how this is relevant to real world problems, finished with an invited public Christmas lecture. Sparked a number of questions and discussions with members of the public, school children and teachers both at the events and subsequently via email and social media. Significant increased interest in the trans-discipline nature of real world science and engineering.
Year(s) Of Engagement Activity 2018
URL https://www.eventbrite.co.uk/e/the-iet-christmas-lecture-tickets-49888592122#
 
Description The Royal Society Networking Event for Industry Fellows Presentation 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Industry/Business
Results and Impact Presentation at the annual networking event in November for the Royal Society Industrial Fellows, including academics, industry, policy advisors, undergraduate and postgraduate students. A number of conversations ranging from core science to policy and the future of healthcare were sparked.
Year(s) Of Engagement Activity 2019
URL https://royalsociety.org/science-events-and-lectures/2019/11/industry-fellows-college/
 
Description UK Society for Cell Culture Biotechnology Invited Talk 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Industry/Business
Results and Impact Invited presentation to outline the scope of this project to a broad audience of specialists currently in the field we intend to disrupt through the project. Sparked a number of conversations about the potential of the technology and a number of contacts made for future pathways to impact for the work.
Year(s) Of Engagement Activity 2018
URL http://www.esactuk.org.uk/index.php/meetings/2018/
 
Description UK-India Researcher Links Workshop on TB Diagnostics - Presentation & Workshop Lead/Mentoring 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Presentation entitled "Bridging the Gap Between Biology, Chemistry, Physics, Engineering & Medicine" in Chennai as part of an invited delegation to the UK-India Researcher Links Workshop on TB Diagnostics. Also sat on an expert panel as part of the delegation talk about bioengineering and also to give career advice to early career, PhD and PDRAs present at the event. Significant follow up interest came from attending the workshop, collaborations made and discussion about the future of healthcare.
Year(s) Of Engagement Activity 2019